Related references
Note: Only part of the references are listed.Early nifurtimox-induced biochemical and ultrastructural alterations in rat heart
L. C. Bartel et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2007)
Etiological treatment in patients infected by Trypanosoma cruzi:: experiences in Argentina
Sergio Sosa-Estani et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Cytochrome P450 enzymes: Central players in cardiovascular health and disease
Reem H. Elbekai et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)
Jose A. Castro et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2006)
Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients
Jian-jun Wen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Long-term cardiac outcomes of treating chronic chagas disease with benznidazole versus no treatment - A nonrandomized trial
Rodolfo Viotti et al.
ANNALS OF INTERNAL MEDICINE (2006)
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations
S Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
The impact of Chagas disease control in Latin America - A review
JCP Dias et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
A critical review on Chagas disease chemotherapy
JR Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
Share Paper
